Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Apply
AMO959, AAA617, ARPI
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step